Neuphoria Therapeutics Inc. SEC filings NEUP

Neuphoria Therapeutics Inc. has 420 filings in SEC EDGAR's recent list, going back to Sep 11, 2002. Its latest annual report, Form 10-K, was filed on Sep 18, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, change to shareholder rights). The company's fiscal year ends on June 30.

Form Description Filed Period
8-K Current report
Material agreement, Change to shareholder rights
 Oct 23, 2026 Oct 23, 2026
8-K Current report
Material agreement, Change in control, Regulation FD disclosure
 Jul 24, 2026 Jul 20, 2026
8-K Current report
Other events
 May 26, 2026 May 21, 2026
8-K Current report
Material agreement, Agreement ended
 Jan 8, 2026 Dec 31, 2025
8-K Current report
Listing notice
 Dec 18, 2025 Dec 18, 2025
8-K Current report
Shareholder vote results
 Dec 17, 2025 Dec 12, 2025
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
 Oct 27, 2025 Oct 27, 2025
8-K Current report
Other events
 Oct 20, 2025 Oct 20, 2025
8-K Current report
Listing notice
 Sep 16, 2025 Sep 10, 2025
8-K Current report
Listing notice
 Jul 18, 2025 Jul 18, 2025
8-K Current report
Results of operations
 May 20, 2025 May 20, 2025
8-K Current report
Other events
 Jan 14, 2025 Jan 10, 2025
8-K Current report
Material agreement, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
 Dec 23, 2024 Dec 23, 2024
8-K Current report
Other events
 Dec 16, 2024 Dec 16, 2024
8-K Current report
Shareholder vote results
 Dec 12, 2024 Dec 11, 2024
8-K Current report
Material agreement
 Nov 21, 2024 Nov 18, 2024
8-K Current report
Other events
 Nov 8, 2024 Nov 8, 2024
8-K Current report
Officer or director change
 Oct 10, 2024 Oct 9, 2024
8-K Current report
Material agreement
 Oct 2, 2024 Oct 1, 2024
8-K Current report
Listing notice
 Jul 16, 2024 Jul 11, 2024
6-K Current report (foreign issuer) Jun 3, 2024 Jun 3, 2024
6-K Current report (foreign issuer) Mar 15, 2024 Mar 15, 2024
6-K Current report (foreign issuer) Jan 4, 2024 Jan 4, 2024
6-K Current report (foreign issuer) Nov 30, 2023 Nov 30, 2023
6-K Current report (foreign issuer) Nov 28, 2023 Nov 28, 2023
6-K Current report (foreign issuer) Nov 3, 2023 Nov 3, 2023
6-K Current report (foreign issuer) Oct 16, 2023 Oct 16, 2023
6-K Current report (foreign issuer) Sep 29, 2023 Sep 29, 2023
6-K Current report (foreign issuer) Sep 28, 2023 Sep 28, 2023
6-K Current report (foreign issuer) Jul 31, 2023 Jul 31, 2023
6-K Current report (foreign issuer) Jul 28, 2023 Jul 28, 2023
6-K Current report (foreign issuer) Jul 25, 2023 Jul 25, 2023
6-K Current report (foreign issuer) Jul 24, 2023 Jul 24, 2023
6-K Current report (foreign issuer) Jul 7, 2023 Jul 7, 2023
6-K Current report (foreign issuer) Jul 7, 2023 Apr 28, 2023
6-K Current report (foreign issuer) Jul 3, 2023 Jul 3, 2023
6-K Current report (foreign issuer) Apr 27, 2023 Apr 27, 2023
6-K Current report (foreign issuer) Mar 9, 2023 Mar 9, 2023
6-K Current report (foreign issuer) Feb 23, 2023 Feb 23, 2023
6-K Current report (foreign issuer) Feb 23, 2023 Feb 23, 2023
6-K Current report (foreign issuer) Feb 21, 2023 Feb 21, 2023
6-K Current report (foreign issuer) Jan 30, 2023 Jan 30, 2023
6-K Current report (foreign issuer) Jan 18, 2023 Jan 18, 2023
6-K Current report (foreign issuer) Jan 9, 2023 Jan 9, 2023
6-K Current report (foreign issuer) Dec 19, 2022 Dec 19, 2022
6-K Current report (foreign issuer) Dec 16, 2022 Dec 16, 2022
6-K Current report (foreign issuer) Nov 16, 2022 Nov 16, 2022
6-K Current report (foreign issuer) Oct 25, 2022 Oct 25, 2022
6-K Current report (foreign issuer) Oct 18, 2022 Oct 18, 2022
6-K Current report (foreign issuer) Oct 18, 2022 Oct 18, 2022
6-K Current report (foreign issuer) Oct 6, 2022 Oct 6, 2022
6-K Current report (foreign issuer) Oct 4, 2022 Oct 4, 2022
6-K Current report (foreign issuer) Sep 21, 2022 Sep 21, 2022
6-K Current report (foreign issuer) Aug 25, 2022 Aug 25, 2022
6-K Current report (foreign issuer) Aug 8, 2022 Aug 8, 2022
6-K Current report (foreign issuer) Jul 29, 2022 Jul 29, 2022
6-K Current report (foreign issuer) Jul 20, 2022 Jul 20, 2022
6-K Current report (foreign issuer) Jul 5, 2022 Jul 5, 2022
6-K Current report (foreign issuer) Jun 13, 2022 Jun 13, 2022
6-K Current report (foreign issuer) May 18, 2022 May 18, 2022
6-K Current report (foreign issuer) May 16, 2022 May 16, 2022
6-K Current report (foreign issuer) Apr 29, 2022 Apr 29, 2022
6-K Current report (foreign issuer) Feb 23, 2022 Jan 31, 2022
6-K Current report (foreign issuer) Jan 28, 2022 Jan 28, 2022
6-K Current report (foreign issuer) Jan 12, 2022 Jan 12, 2022
6-K Current report (foreign issuer) Jan 4, 2022 Jan 4, 2022
6-K Current report (foreign issuer) Jan 3, 2022 Jan 3, 2022
6-K Current report (foreign issuer) Dec 22, 2021 Dec 22, 2021

Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NEUP (Nasdaq)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Burlington, MA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1191070
Former names
BIONOMICS LIMITED/FI (until Dec 23, 2024)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.